Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Clinical trial NCT06848348 · RECRUITING
Trial details
- NCT number
- NCT06848348
- Sponsor
- Dogwood Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-21
- Primary completion
- 2026-07-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.